Historical record - last NADAC effective date: 2/22/2017
Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0410 per EA under NDC 65862019001. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Sep 26, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862019001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078643FDA Approved
9/26/2008
TE Code
AB
On Market Since
9/26/2008
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0410 per EA |
|---|---|
| All-time high | $0.0533 (Feb 12, 2014) |
| All-time low | $0.0376 (Nov 18, 2015) |
| Median price | $0.0441 |
| Average price | $0.0438 |
| Largest weekly change | -17.9% (Jan 18, 2017) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-7.0%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0410 per EA (NDC 65862019001), effective Feb 22, 2017.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 7.0%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0376 (Nov 18, 2015) to a high of $0.0533 (Feb 12, 2014), with a median of $0.0441 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOBENZAPRINE 5 MG TABLET, is $0.0215 per EA — about 48% below CYCLOBENZAPRINE 5 MG TABLET.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 65862019001) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.